Q3 earnings recap: Winners, losers & surprises
Release Date:
This week (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
Want to dive deeper on BioSpace? Read more on Pfizer's recent cuts as part of their cost-savings program and more insight on Q3 earnings for Gilead, Novo Nordisk, Moderna, Vertex, BMS, Lilly, GSK.
Meanwhile, industry-wide layoffs march on and in case you missed it - bankruptcies reached a record high.
Q3 earnings recap: Winners, losers & surprises